Cargando…

Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization

Llamas (Lama glama) naturally produce heavy chain–only antibodies (Abs) in addition to conventional Abs. The variable regions (VHH) in these heavy chain–only Abs demonstrate comparable affinity and specificity for antigens to conventional immunoglobulins despite their much smaller size. To date, imm...

Descripción completa

Detalles Bibliográficos
Autores principales: McCoy, Laura E., Quigley, Anna Forsman, Strokappe, Nika M., Bulmer-Thomas, Bianca, Seaman, Michael S., Mortier, Daniella, Rutten, Lucy, Chander, Nikita, Edwards, Carolyn J., Ketteler, Robin, Davis, David, Verrips, Theo, Weiss, Robin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371729/
https://www.ncbi.nlm.nih.gov/pubmed/22641382
http://dx.doi.org/10.1084/jem.20112655
_version_ 1782235247418540032
author McCoy, Laura E.
Quigley, Anna Forsman
Strokappe, Nika M.
Bulmer-Thomas, Bianca
Seaman, Michael S.
Mortier, Daniella
Rutten, Lucy
Chander, Nikita
Edwards, Carolyn J.
Ketteler, Robin
Davis, David
Verrips, Theo
Weiss, Robin A.
author_facet McCoy, Laura E.
Quigley, Anna Forsman
Strokappe, Nika M.
Bulmer-Thomas, Bianca
Seaman, Michael S.
Mortier, Daniella
Rutten, Lucy
Chander, Nikita
Edwards, Carolyn J.
Ketteler, Robin
Davis, David
Verrips, Theo
Weiss, Robin A.
author_sort McCoy, Laura E.
collection PubMed
description Llamas (Lama glama) naturally produce heavy chain–only antibodies (Abs) in addition to conventional Abs. The variable regions (VHH) in these heavy chain–only Abs demonstrate comparable affinity and specificity for antigens to conventional immunoglobulins despite their much smaller size. To date, immunizations in humans and animal models have yielded only Abs with limited ability to neutralize HIV-1. In this study, a VHH phagemid library generated from a llama that was multiply immunized with recombinant trimeric HIV-1 envelope proteins (Envs) was screened directly for HIV-1 neutralization. One VHH, L8CJ3 (J3), neutralized 96 of 100 tested HIV-1 strains, encompassing subtypes A, B, C, D, BC, AE, AG, AC, ACD, CD, and G. J3 also potently neutralized chimeric simian-HIV strains with HIV subtypes B and C Env. The sequence of J3 is highly divergent from previous anti–HIV-1 VHH and its own germline sequence. J3 achieves broad and potent neutralization of HIV-1 via interaction with the CD4-binding site of HIV-1 Env. This study may represent a new benchmark for immunogens to be included in B cell–based vaccines and supports the development of VHH as anti–HIV-1 microbicides.
format Online
Article
Text
id pubmed-3371729
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-33717292012-12-04 Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization McCoy, Laura E. Quigley, Anna Forsman Strokappe, Nika M. Bulmer-Thomas, Bianca Seaman, Michael S. Mortier, Daniella Rutten, Lucy Chander, Nikita Edwards, Carolyn J. Ketteler, Robin Davis, David Verrips, Theo Weiss, Robin A. J Exp Med Article Llamas (Lama glama) naturally produce heavy chain–only antibodies (Abs) in addition to conventional Abs. The variable regions (VHH) in these heavy chain–only Abs demonstrate comparable affinity and specificity for antigens to conventional immunoglobulins despite their much smaller size. To date, immunizations in humans and animal models have yielded only Abs with limited ability to neutralize HIV-1. In this study, a VHH phagemid library generated from a llama that was multiply immunized with recombinant trimeric HIV-1 envelope proteins (Envs) was screened directly for HIV-1 neutralization. One VHH, L8CJ3 (J3), neutralized 96 of 100 tested HIV-1 strains, encompassing subtypes A, B, C, D, BC, AE, AG, AC, ACD, CD, and G. J3 also potently neutralized chimeric simian-HIV strains with HIV subtypes B and C Env. The sequence of J3 is highly divergent from previous anti–HIV-1 VHH and its own germline sequence. J3 achieves broad and potent neutralization of HIV-1 via interaction with the CD4-binding site of HIV-1 Env. This study may represent a new benchmark for immunogens to be included in B cell–based vaccines and supports the development of VHH as anti–HIV-1 microbicides. The Rockefeller University Press 2012-06-04 /pmc/articles/PMC3371729/ /pubmed/22641382 http://dx.doi.org/10.1084/jem.20112655 Text en © 2012 McCoy et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
spellingShingle Article
McCoy, Laura E.
Quigley, Anna Forsman
Strokappe, Nika M.
Bulmer-Thomas, Bianca
Seaman, Michael S.
Mortier, Daniella
Rutten, Lucy
Chander, Nikita
Edwards, Carolyn J.
Ketteler, Robin
Davis, David
Verrips, Theo
Weiss, Robin A.
Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
title Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
title_full Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
title_fullStr Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
title_full_unstemmed Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
title_short Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
title_sort potent and broad neutralization of hiv-1 by a llama antibody elicited by immunization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371729/
https://www.ncbi.nlm.nih.gov/pubmed/22641382
http://dx.doi.org/10.1084/jem.20112655
work_keys_str_mv AT mccoylaurae potentandbroadneutralizationofhiv1byallamaantibodyelicitedbyimmunization
AT quigleyannaforsman potentandbroadneutralizationofhiv1byallamaantibodyelicitedbyimmunization
AT strokappenikam potentandbroadneutralizationofhiv1byallamaantibodyelicitedbyimmunization
AT bulmerthomasbianca potentandbroadneutralizationofhiv1byallamaantibodyelicitedbyimmunization
AT seamanmichaels potentandbroadneutralizationofhiv1byallamaantibodyelicitedbyimmunization
AT mortierdaniella potentandbroadneutralizationofhiv1byallamaantibodyelicitedbyimmunization
AT ruttenlucy potentandbroadneutralizationofhiv1byallamaantibodyelicitedbyimmunization
AT chandernikita potentandbroadneutralizationofhiv1byallamaantibodyelicitedbyimmunization
AT edwardscarolynj potentandbroadneutralizationofhiv1byallamaantibodyelicitedbyimmunization
AT kettelerrobin potentandbroadneutralizationofhiv1byallamaantibodyelicitedbyimmunization
AT davisdavid potentandbroadneutralizationofhiv1byallamaantibodyelicitedbyimmunization
AT verripstheo potentandbroadneutralizationofhiv1byallamaantibodyelicitedbyimmunization
AT weissrobina potentandbroadneutralizationofhiv1byallamaantibodyelicitedbyimmunization